Lee Philina
- SEC CIK
- 0001845080
No open-market purchases or sales filed in the past year.
Current role at each company
- BPMC Blueprint Medicines CorpChief Commercial Officeras of Jul 21, 2025
- FUSN Fusion Pharmaceuticals Inc.Directoras of Jun 4, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lee Philina as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BPMC Blueprint Medicines Corp
Chief Commercial Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Lee PhilinaCHIEF COMMERCIAL OFFICER | SSale | −3.73K | $88.80 | −$331.5K | −8.2%42.0K after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Lee PhilinaCHIEF COMMERCIAL OFFICER | SSale | −41.9K | $93.19 | −$3.91M | −54.7%34.7K after | |
| Mar 15, 2024 (view filing) | Mar 13 | 2 days | Lee PhilinaCHIEF COMMERCIAL OFFICER | SSale | −8.02K | $90.40 | −$725.3K | −18.8%34.7K after | 2 lots |
| Mar 11, 2024 (view filing) | Mar 7 | 4 days | Lee PhilinaCHIEF COMMERCIAL OFFICER | SSale | −2.93K | $90.69 | −$266.1K | −6.7%41.0K after | |
| Mar 8, 2023 (view filing) | Mar 6 | 2 days | Lee PhilinaCHIEF COMMERCIAL OFFICER | SSale | −1.68K | $45.68 | −$76.6K | −5.1%31.2K after | 2 lots |